Carlos Javier Alméciga-Díaz

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Human recombinant lysosomal β‐Hexosaminidases produced in Pichia pastoris efficiently reduced lipid accumulation in Tay‐Sachs fibroblasts”.

Human recombinant lysosomal β‐Hexosaminidases produced in Pichia pastoris efficiently reduced lipid accumulation in Tay‐Sachs fibroblasts

American Journal of Medical Genetics Part C Seminars in Medical Genetics(2020)10.1002/ajmg.c.31849

N/A

0DataRank · unranked

14 citations

Alexander Rodríguez‐López, Rong Li, Wei Zheng, Carlos Javier Alméciga-Díaz, Cindy Dulcey‐Sepúlveda +3 more

Iron oxide-coupled CRISPR-nCas9-based genome editing assessment in mucopolysaccharidosis IVA mice

Molecular Therapy — Methods & Clinical Development(2023)10.1016/j.omtm.2023.101153

N/A

0DataRank · unranked

19 citations

Betül Çelik, Nidhi Fnu, Shaukat Khan, Shunji Tomatsu, Carlos Javier Alméciga-Díaz +1 more

Mucopolysaccharidosis IVA: Current Disease Models and Drawbacks

International Journal of Molecular Sciences(2023)10.3390/ijms242216148

N/A

0DataRank · unranked

13 citations

Carlos Javier Alméciga-Díaz, Shunji Tomatsu, Andrés Felipe Leal

CRISPR/nCas9-Edited CD34+ Cells Rescue Mucopolysaccharidosis IVA Fibroblasts Phenotype

International Journal of Molecular Sciences(2025)10.3390/ijms26094334

N/A

0DataRank · unranked

6 citations

Andrés Felipe Leal, Shaukat Khan, Carlos Javier Alméciga-Díaz, Shunji Tomatsu, Angelica María Herreño-Pachón